Baxter is among several vaccinemakers working with the WHO and the U.S. Centers for Disease Control and Prevention to combat the swine flu.

Briefings
Baxter: Swine flu vaccine due in July
June 13, 2009
Baxter International Inc. said it is in "full scale" production of a vaccine for the H1N1 virus, known as swine flu, and anticipates the first commercially available dosages to be ready in early July.The announcement Friday by the Deerfield-based medical-product giant comes a day after the World Health Organization declared a global pandemic.Baxter is believed to be a leader in cell-based technology, which allows the company to cut production times roughly in half compared with the older process that involves processing by hand millions of chicken eggs.The cell-based method can generate yields in about 13 weeks, compared with 24 weeks in egg-based manufacturing, Baxter said.
Baxter is among several vaccinemakers working with the WHO and the U.S. Centers for Disease Control and Prevention to combat the swine flu.